C3652633_Pharmacokynetic_C0772024 | Knowledge4COVID-19

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C2348767>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	decrease
?:interaction	The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Aluminium acetoacetate. The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Aluminium acetoacetate.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0772024>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB14502> <https://research.tib.eu/covid-19/entity/DB14504>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C3652633>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB13280>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction> <https://research.tib.eu/covid-19/vocab/PharmacokyneticDrugDrugInteraction>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C3652633_Pharmacokynetic_C0772024>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C3652633_Pharmacokynetic_C0772024>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all